Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.

被引：0
|
作者：
Russo, Ricardo A. [1 ]
Katsicas, Maria M. [1 ]
机构：
[1] Hosp Pediat, Buenos Aires, DF, Argentina
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S681 / S682
页数：2
相关论文
共 50 条
  • [41] Safety and Efficacy of Etanercept in 2000 Patients with Juvenile Idiopathic Arthritis (JIA) in the JIA Biologics Register
    Horneff, Gerd
    Brunner, Juergen
    Haas, Johannes Peter
    Ganser, Gerd
    Foeldvari, Ivan
    Hospach, Toni
    Minden, Kirsten
    Huppertz, Hans-Iko
    Kuester, Rolf M.
    Trauzeddel, Ralf
    Thon, Angelika
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] Efficacy of etanercept in polyarticular course juvenile rheumatoid arthritis.
    Kietz, DA
    Pepmueller, PH
    Moore, TL
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S183 - S183
  • [43] A comparison of response criteria in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-TNFα agents
    Lurati, A
    Pontikaki, I
    Teruzzi, B
    Desiati, F
    Gerloni, V
    Gattinara, M
    Cimaz, R
    Fantini, F
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S91 - S91
  • [44] Safety and Efficacy of Tocilizumab Treatment In Children with Systemic Juvenile Idiopathic Arthritis.
    Alexeeva, Ekaterina
    Denisova, Rina
    Valieva, Saniya
    Bzarova, Tatyana
    Isayeva, Kseniya
    Sleptsova, Tatyana
    Mitenko, Elena
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S109 - S109
  • [45] Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis
    Murdaca, Giuseppe
    Negrini, Simone
    Magnani, Ottavia
    Penza, Elena
    Pellecchio, Marco
    Gulli, Rossella
    Mandich, Paola
    Puppo, Francesco
    MODERN RHEUMATOLOGY, 2018, 28 (03) : 417 - 431
  • [46] Therapeutic efficacy of humanized anti-IL-6-receptor antibody in systemic juvenile idiopathic arthritis.
    Yokota, S
    Miyamae, T
    Imagawa, T
    Nishimoto, N
    Yoshizaki, K
    Hirsch, R
    Mori, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S291 - S291
  • [47] Long Term Safety and Efficacy of Etanercept in Juvenile Idiopathic Arthritis in a Single Center
    Bang, Myung Hoon
    Kim, Kwang Nam
    JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (03): : 200 - 205
  • [48] Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis
    Pires da Silva, Barbara Santos
    Bonfa, Eloisa
    Bertacini de Moraes, Julio Cesar
    Schain Saad, Carla Goncalves
    de Medeiros Ribeiro, Ana Cristina
    Goncalves, Celio Roberto
    de Carvalho, Jozelio Freire
    BIOLOGICALS, 2010, 38 (05) : 567 - 569
  • [49] Pharmacokinetics and pharmacodynamics of a human anti-TNF-alpha monoclonal antibody in patients with rheumatoid arthritis.
    Jang, H
    Marini, JC
    Pendley, C
    Jiao, Q
    Marciniak, SJ
    Cohen, S
    Fleischmann, R
    Everitt, DE
    Davis, HM
    Graham, MA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P53 - P53
  • [50] Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis
    Lanlan Ge
    Yu Gao
    Xin Chen
    Jingxiao Guo
    Dongfeng Zhang
    Yanjun Yang
    BMC Pediatrics, 25 (1)
12345